In vivo binding properties of SH2 domains from GTPase-activating protein and phosphatidylinositol 3-kinase
about
Hierarchy of binding sites for Grb2 and Shc on the epidermal growth factor receptorThe 64-kDa protein that associates with the platelet-derived growth factor receptor beta subunit via Tyr-1009 is the SH2-containing phosphotyrosine phosphatase SypAlpha 2-chimerin, an SH2-containing GTPase-activating protein for the ras-related protein p21rac derived by alternate splicing of the human n-chimerin gene, is selectively expressed in brain regions and testesThymocyte activation induces the association of the proto-oncoprotein c-cbl and ras GTPase-activating protein with CD5Localization of the insulin-like growth factor I receptor binding sites for the SH2 domain proteins p85, Syp, and GTPase activating proteinCloning of a novel, ubiquitously expressed human phosphatidylinositol 3-kinase and identification of its binding site on p85The MATK tyrosine kinase interacts in a specific and SH2-dependent manner with c-KitInteraction of p72syk with the gamma and beta subunits of the high-affinity receptor for immunoglobulin E, Fc epsilon RIRegulation of the p85/p110alpha phosphatidylinositol 3'-kinase. Distinct roles for the n-terminal and c-terminal SH2 domains.p80/85 cortactin associates with the Src SH2 domain and colocalizes with v-Src in transformed cells.Binding of the Src SH2 domain to phosphopeptides is determined by residues in both the SH2 domain and the phosphopeptides.A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo.Inhibition of platelet-derived growth factor- and epidermal growth factor-mediated mitogenesis and signaling in 3T3 cells expressing delta Raf-1:ER, an estradiol-regulated form of Raf-1.Sequential activation of phoshatidylinositol 3-kinase and phospholipase C-gamma2 by the M-CSF receptor is necessary for differentiation signalingRasGAP Promotes Autophagy and Thereby Suppresses Platelet-Derived Growth Factor Receptor-Mediated Signaling Events, Cellular Responses, and Pathology.Differential Regulation of RasGAPs in Cancer.Competitive binding of Rab21 and p120RasGAP to integrins regulates receptor traffic and migration.Profiling the global tyrosine phosphorylation state.Conformational changes induced in the protein tyrosine kinase p72syk by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides.Aberrant Ras regulation and reduced p190 tyrosine phosphorylation in cells lacking p120-Gap.Phosphatidylinositol 3-kinase activation is mediated by high-affinity interactions between distinct domains within the p110 and p85 subunits.A new function for a phosphotyrosine phosphatase: linking GRB2-Sos to a receptor tyrosine kinase.Molecular mechanisms involved in Ras inactivation: the annexin A6-p120GAP complex.Epstein-Barr virus latent membrane protein 2A preferentially signals through the Src family kinase LynNonredundant functions for Ras GTPase-activating proteins in tissue homeostasis.Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling.Characterization of the roles of SH2 domain-containing proteins in T-lymphocyte activation by using dominant negative SH2 domains.Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research.PI 3-kinase: structural and functional analysis of intersubunit interactions.Kinetic analysis of platelet-derived growth factor receptor/phosphoinositide 3-kinase/Akt signaling in fibroblasts.Differences in survival-promoting effects and intracellular signaling properties of BDNF and IGF-1 in cultured cerebral cortical neurons.Annexin A6 inhibits Ras signalling in breast cancer cells.
P2860
Q24305821-F8E7F31C-0609-4230-A639-415902EF6E51Q24310396-33F6665A-211F-496C-8068-004A06C4AE39Q24310421-A46B493A-B06C-4ACD-BC8F-956D037B7792Q24319914-F82834F4-9B10-4AF3-A1C4-0038A547BB37Q24323283-696A1DE5-5B33-481D-A7F7-E546DD7D556DQ24629213-29350ACF-7E0B-4EFE-BD37-B44BC7267F5FQ28287741-7FDF874A-8580-4BA3-AC37-B12EF4587F84Q28611006-1D69BCB5-483C-42AB-99F2-9C4BFD6FE63EQ30175992-7067E7D8-9A5C-496E-9BF9-8F043AD76798Q30192960-6C934F51-8A3D-401E-BB57-A6AD05FEDF71Q30194700-55090F9E-1774-4A78-82E1-AFCA362FACB3Q30194817-2F6DD5B7-89BF-488C-97FE-70ED20BC69ACQ30450197-C105C3C8-5EE6-491B-AF34-2FD0CAF34CBAQ33887555-F2B2D627-9578-4DDF-8D32-F98F638486DDQ34465364-74C683BC-39B6-48D1-9369-94DAD5AF37CCQ35083732-F45B96A1-538F-4B18-8AD5-E2C98F26B64FQ35130176-0478209B-72DE-4B15-8987-5A633D40AA10Q35130207-0C258813-D685-42C3-AA74-1F3D3B266B56Q36557865-5972CA2D-BB0C-4F38-B276-42F55F250783Q36567460-93462E3F-4E67-45C7-BDA5-CA9855437B6DQ36642568-3C2957D2-2D7D-45EB-9469-51A72D478303Q36643931-0D7A7296-F3E0-44CF-8752-4E1C7FC984C7Q36660575-DEB1C167-F984-4083-88E6-B8EF2547282CQ36845865-50EC3A73-4B90-49DF-83FC-C1BBF5A73DEEQ38084894-9C9A4697-E309-45BD-B72B-213C437BE444Q39457155-612D8F8D-4A3E-47A7-B06D-64BE49C9987CQ40018783-BD55065A-A7C4-45FD-AB8C-C6AF61B3D56EQ40445359-B29EEF9F-C46B-4FE4-A654-8412D68A178BQ40790710-BB63C18C-7D28-4BF7-9CBD-FA874813B785Q42799203-C20B54FB-E023-4DB6-9CDB-CF6E2E00C7B4Q48794541-5C93175C-4F27-4A6C-94B9-D4BDA0C1B1B4Q51785771-D8792D21-23E2-4894-B475-FD92FCB53BC6
P2860
In vivo binding properties of SH2 domains from GTPase-activating protein and phosphatidylinositol 3-kinase
description
1993 nî lūn-bûn
@nan
1993 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մարտին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
In vivo binding properties of ...... phosphatidylinositol 3-kinase
@ast
In vivo binding properties of ...... phosphatidylinositol 3-kinase
@en
In vivo binding properties of ...... phosphatidylinositol 3-kinase
@en-gb
In vivo binding properties of ...... phosphatidylinositol 3-kinase
@nl
type
label
In vivo binding properties of ...... phosphatidylinositol 3-kinase
@ast
In vivo binding properties of ...... phosphatidylinositol 3-kinase
@en
In vivo binding properties of ...... phosphatidylinositol 3-kinase
@en-gb
In vivo binding properties of ...... phosphatidylinositol 3-kinase
@nl
prefLabel
In vivo binding properties of ...... phosphatidylinositol 3-kinase
@ast
In vivo binding properties of ...... phosphatidylinositol 3-kinase
@en
In vivo binding properties of ...... phosphatidylinositol 3-kinase
@en-gb
In vivo binding properties of ...... phosphatidylinositol 3-kinase
@nl
P2860
P356
P1476
In vivo binding properties of ...... phosphatidylinositol 3-kinase
@en
P2093
A Kashishian
J A Cooper
P2860
P304
P356
10.1128/MCB.13.3.1737
P407
P577
1993-03-01T00:00:00Z